Abpro Holdings Inc. (NASDAQ:ABP) Sees Significant Increase in Short Interest

Abpro Holdings Inc. (NASDAQ:ABP) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 3,190,000 shares, a growth of 68.8% from the September 15th total of 1,890,000 shares. Based on an average daily trading volume, of 10,040,000 shares, the short-interest ratio is currently 0.3 days. Approximately 9.2% of the shares of the company are sold short. Approximately 9.2% of the shares of the company are sold short. Based on an average daily trading volume, of 10,040,000 shares, the short-interest ratio is currently 0.3 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Abpro stock. Goldman Sachs Group Inc. purchased a new stake in shares of Abpro Holdings Inc. (NASDAQ:ABP) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 72,106 shares of the company’s stock, valued at approximately $30,000. Goldman Sachs Group Inc. owned 0.14% of Abpro as of its most recent filing with the Securities and Exchange Commission (SEC). 23.30% of the stock is currently owned by institutional investors and hedge funds.

Abpro Price Performance

Shares of ABP opened at $0.20 on Wednesday. Abpro has a one year low of $0.15 and a one year high of $13.00. The stock’s fifty day moving average is $0.22 and its 200-day moving average is $0.23.

Abpro (NASDAQ:ABP) last issued its quarterly earnings results on Wednesday, August 13th. The company reported ($0.04) EPS for the quarter.

Analyst Upgrades and Downgrades

ABP has been the topic of several analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Abpro in a research report on Wednesday, October 8th. Maxim Group reaffirmed a “hold” rating on shares of Abpro in a research report on Tuesday. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $4.00.

Abpro Company Profile

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.